Company Overview of Oncos Therapeutics Ltd
Oncos Therapeutics Ltd., a clinical-stage biotechnology company, develops and commercializes targeted cancer immunotherapy products. It offers ONCOS-102, an engineered human serotype 5 adenovirus optimized to induce systemic anti-tumor T cell response in cancer patients. The company also engages in the development of products using its adenovirus-based cancer immunotherapy platform for the treatment of various cancer types, including soft tissue sarcoma, ovarian cancer, and mesothelioma. Oncos Therapeutics Ltd. was founded in 2009 and is based in Helsinki, Finland.
Founded in 2009
358 4073 00445
358 9856 57321
Key Executives for Oncos Therapeutics Ltd
Oncos Therapeutics Ltd Key Developments
Similar Private Companies By Industry
|Labsystems, CLIDS Automation, Konelab||Europe|
Recent Private Companies Transactions
June 11, 2015
To contact Oncos Therapeutics Ltd, please visit www.oncos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.